Summary of adverse experiences associated with intravenous augmentation therapy
| Adverse effect | Wencker et al15* (n = 443 patients) | Stoller et al16† (n = 747 patients) |
|---|---|---|
| *Percentage of patients. | ||
| †Percentage of total of 720 adverse events. | ||
| NR, not reported. | ||
| Anaphylaxis | 0.9% | 0 |
| Dyspnea | 3.0% | 8.5% |
| Wheezing | NR | 1.9% |
| Hypotension | NR | 0.3% |
| Headache | NR | 47.1% |
| Dizziness (fainting) | NR | 16.8% |
| Chills | 7.5% | |
| Fever | 3.8% | 7.4% |
| Rash | NR | 5.1% |
| Chest tightness | NR | 5.1% |
| Hives/itching | 4.1% | 3.2% |
| Tachycardia | NR | 2.8% |
| Moderate chest pain | 2.2% | |
| Emesis/nausea | 4.7% | 1.7% |
| Flushing | NR | 6.5% |
| Anxiety | NR | 4.4% |
| Mild pain | NR | 4.3% |
| Muscle cramps | NR | 3.8% |
| Fatigue | 1.6% | NR |